New research has suggested that a new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in phase I clinical trials. The study is published on August 27, 2014, in iNeurology (Regd) Neuroimmunology (and) Neuroinflammation/i, a new online-only, freely accessible, specialty medical journal. The publication is part of the iNeurology (Regd) /i family of journals, published by the American Academy of Neurology. The phase I studies were ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1pa5zEU
No comments:
Post a Comment